Irish pharmaceutical giant Shire has rejected a £44bn takeover approach from larger rival Takeda, but left the door open for further talks that could pave the way for the largest ever cross border acquisition by a Japanese company.

Takeda proposed a deal to the Dublin-headquartered firm last week of £46.50 per share in cash and its own stock, according to separate statements from the two companies today — its third such proposal since late March.